NASDAQ:RPTP - (RPTP) Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00 %
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$9.00
+0.30 (1.20%)
Get New (RPTP) Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for RPTP and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for RPTP

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for (RPTP) in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $9.00.

This chart shows the closing price for RPTP for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is N/A

The current consensus among 0 investment analysts is to n/a stock in (RPTP). This N/A consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
2/12/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/12/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
8/10/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
11/8/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
2/6/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/7/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/6/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
8/5/2021

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
9/16/2016CowenDowngradeOutperform ➝ Market Perform$9.00N/A
9/12/2016WedbushReiterated RatingNeutral$9.00 ➝ $4.00N/A
9/8/2016(FBRC)Reiterated RatingHoldN/A
8/23/2016(FBRC)Reiterated RatingHold$10.00N/A
8/19/2016CowenReiterated RatingBuy$8.00N/A
8/8/2016CitigroupDowngradeBuy ➝ Neutral$6.00 ➝ $8.00N/A
(Data available from 8/5/2016 forward)
(RPTP) logo
Raptor Pharmaceutical Corp. (Raptor) is a biopharmaceutical company. The Company is focused on developing and commercializing transformative treatments for people affected by diseases. Its product, PROCYSBI (cysteamine bitartrate) is a delayed-release capsules for the management of nephropathic cystinosis in adults and children of over six years. In Europe, PROCYSBI gastro-resistant hard capsules of cysteamine (as mercaptamine bitartrate), is indicated as an orphan medicinal product for the management of nephropathic cystinosis. Its QUINSAIR is a formulation of the antibiotic drug levofloxacin, suitable for inhalation via a nebulizer. It is engaged in developing MP-376 for non-CF bronchiectasis (BE) and nontuberculous mycobacteria (NTM) lung infections. It is also engaged in developing RP105 and RP106 for various diseases.
Read More

Today's Range

Now: $9.00
Low: $9.00
High: $9.00

50 Day Range

MA: N/A

52 Week Range

Now: $9.00
Low: $2.94
High: $9.05

Volume

N/A

Average Volume

1,424,969 shs

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of (RPTP)?

The following Wall Street sell-side analysts have issued stock ratings on (RPTP) in the last year:
View the latest analyst ratings for RPTP.

What is the current price target for (RPTP)?

0 Wall Street analysts have set twelve-month price targets for (RPTP) in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for (RPTP) in the next year.
View the latest price targets for RPTP.

What is the current consensus analyst rating for (RPTP)?

(RPTP) currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for RPTP.

What other companies compete with (RPTP)?

How do I contact (RPTP)'s investor relations team?

(RPTP)'s physical mailing address is 7 Hamilton Lndg Ste 100, NOVATO, CA 94949-8283, United States. The biotechnology company's listed phone number is +1-415-4086200. The official website for (RPTP) is www.horizonpharma.com.